Cowen Starts Avalanche Biotechnologies (AAVL) at Outperform
Tweet
Share
E-mailGet Alerts AAVL Hot Sheet
Price: $4.14 --0%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Cowen initiated coverage on Avalanche Biotechnologies (NASDAQ: AAVL) with an Outperform rating and a price target of $45.00.
For an analyst ratings summary and ratings history on Avalanche Biotechnologies click here. For more ratings news on Avalanche Biotechnologies click here.
Shares of Avalanche Biotechnologies closed at $30.52 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
- BofA Securities Starts Dollarama Inc. (DOL:CN) (DLMAF) at Buy
- Hovde Group Resumes Hancock Whitney (HWC) at Market Perform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
